FABP4 and rectal cancer: We observed increased mortality estimates for higher pre‐diagnostic circulating FABP‐4 in participants with distal colon cancer but not with proximal colon or rectal cancer, which may be due to obesity‐related inflammation interacting with the unique molecular traits of distal tumors, potentially worsening tumor aggressiveness.5